Mitochondrial genome mutations in hypertensive individuals

Area of Science:

• Genetics
• Cardiovascular Disease
• Mitochondrial Biology

Background:

• Essential hypertension (HTN) is a complex, multifactorial disorder with unknown etiology.
• Observed maternal transmission patterns in HTN suggest potential mitochondrial genome involvement.

Purpose of the Study:

• To systematically screen for and identify potentially pathogenic mitochondrial DNA (mtDNA) mutations contributing to HTN.
• To assess the role of the mitochondrial genome in the pathogenesis of hypertension.

Main Methods:

• Applied novel tests to detect mitochondrial mutation involvement in hypertension datasets from 350 white and 98 African American pedigrees.
• Sequenced the entire mitochondrial genome of probands from 20 pedigrees (10 white, 10 African American) with likely mitochondrial involvement.
• Compared sequences to the reference Cambridge sequence to identify base changes.

Main Results:

• Identified 297 base changes in the mitochondrial genome compared to the reference sequence.
• Detected 24 mutations in ribosomal RNA (rRNA) genes and 15 in transfer RNA (tRNA) genes.
• Found 30 novel coding region mutations, with 13 hypertensive probands carrying at least one novel variant, often with known polymorphisms linked to cardiovascular and renal issues.

Conclusions:

• The study identified novel mitochondrial DNA variants in hypertensive individuals.
• These findings suggest a potential role for mitochondrial dysfunction in the etiology of essential hypertension.
• The data provide a foundation for large-scale association studies to confirm the link between mtDNA mutations and HTN.